FREE Event: How to Profit from the Massive Upcoming Revival in Smallcaps
Here is the latest financial fact sheet of Cadila Healthcare. For more details, see the Cadila Healthcare quarterly results and Cadila Healthcare share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | 1.9 |
No. of shares | m | 1,023.74 |
% ch week | % | -0.6 |
% ch 1-mth | % | 3.3 |
% ch 12-mth | % | 83.2 |
52 week H/L | Rs | 509.4/212.7 |
No. of Mths Year Ending |
12 Mar-16* |
12 Mar-17* |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
5-Yr Chart Click to enlarge
|
---|
CADILA HEALTHCARE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 454 | 460 | 558 | 432 | 352 | |
Low | Rs | 305 | 305 | 362 | 306 | 207 | |
Sales per share (Unadj.) | Rs | 92.1 | 91.6 | 116.3 | 128.6 | 139.2 | |
Earnings per share (Unadj.) | Rs | 19.2 | 14.8 | 17.9 | 18.5 | 11.8 | |
Diluted earnings per share | Rs | 19.2 | 14.8 | 17.9 | 18.5 | 11.8 | |
Cash flow per share (Unadj.) | Rs | 22.0 | 18.5 | 23.1 | 24.4 | 18.6 | |
Dividends per share (Unadj.) | Rs | 3.20 | 3.20 | 3.50 | 3.50 | 3.50 | |
Adj. dividends per share | Rs | 3.20 | 3.20 | 3.50 | 3.50 | 3.50 | |
Dividend yield (eoy) | % | 0.8 | 0.8 | 0.8 | 0.9 | 1.3 | |
Book value per share (Unadj.) | Rs | 55.7 | 68.0 | 85.4 | 101.5 | 101.4 | |
Adj. book value per share | Rs | 55.7 | 68.0 | 85.4 | 101.5 | 101.4 | |
Shares outstanding (eoy) | m | 1,023.74 | 1,023.74 | 1,023.74 | 1,023.74 | 1,023.74 | |
Bonus/Rights/Conversions | FV5:1 | - | - | - | - | ||
Price / Sales ratio | x | 4.1 | 4.2 | 4.0 | 2.9 | 2.0 | |
Avg P/E ratio | x | 19.8 | 25.8 | 25.7 | 19.9 | 23.7 | |
P/CF ratio (eoy) | x | 17.2 | 20.7 | 19.9 | 15.1 | 15.0 | |
Price / Book Value ratio | x | 6.8 | 5.6 | 5.4 | 3.6 | 2.8 | |
Dividend payout | % | 16.7 | 21.6 | 19.6 | 18.9 | 29.8 | |
Avg Mkt Cap | Rs m | 388,458 | 391,581 | 470,664 | 378,170 | 286,033 | |
No. of employees | `000 | 15.4 | 16.9 | 11.8 | 12.4 | 13.4 | |
Total wages/salary | Rs m | 12,616 | 15,198 | 18,545 | 21,241 | 24,145 | |
Avg. sales/employee | Rs Th | 6,105.0 | 5,563.0 | 10,072.7 | 10,585.0 | 10,632.7 | |
Avg. wages/employee | Rs Th | 817.0 | 901.7 | 1,569.1 | 1,707.8 | 1,801.2 | |
Avg. net profit/employee | Rs Th | 1,272.1 | 901.5 | 1,547.7 | 1,526.5 | 898.5 |
CADILA HEALTHCARE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 94,268 | 93,765 | 119,049 | 131,656 | 142,531 | |
Other income | Rs m | 1,156 | 1,284 | 1,132 | 2,011 | 1,139 | |
Total revenues | Rs m | 95,424 | 95,049 | 120,181 | 133,667 | 143,670 | |
Gross profit | Rs m | 23,305 | 19,044 | 28,475 | 29,731 | 24,198 | |
Depreciation | Rs m | 2,921 | 3,733 | 5,388 | 5,986 | 6,965 | |
Interest | Rs m | 528 | 446 | 911 | 1,935 | 3,418 | |
Profit before tax | Rs m | 21,012 | 16,149 | 23,308 | 23,821 | 14,954 | |
Minority Interest | Rs m | 430 | 338 | 628 | 469 | 288 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | -25 | -3 | 0 | 0 | 0 | |
Tax | Rs m | 1,774 | 1,289 | 5,644 | 5,303 | 3,198 | |
Profit after tax | Rs m | 19,643 | 15,195 | 18,292 | 18,987 | 12,044 | |
Gross profit margin | % | 24.7 | 20.3 | 23.9 | 22.6 | 17.0 | |
Effective tax rate | % | 8.4 | 8.0 | 24.2 | 22.3 | 21.4 | |
Net profit margin | % | 20.8 | 16.2 | 15.4 | 14.4 | 8.5 |
CADILA HEALTHCARE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 42,804 | 60,223 | 82,005 | 84,981 | 87,154 | |
Current liabilities | Rs m | 34,610 | 53,058 | 60,720 | 73,425 | 82,694 | |
Net working cap to sales | % | 8.7 | 7.6 | 17.9 | 8.8 | 3.1 | |
Current ratio | x | 1.2 | 1.1 | 1.4 | 1.2 | 1.1 | |
Inventory Days | Days | 52 | 70 | 73 | 75 | 71 | |
Debtors Days | Days | 68 | 89 | 98 | 110 | 94 | |
Net fixed assets | Rs m | 46,987 | 72,984 | 83,703 | 133,493 | 133,236 | |
Share capital | Rs m | 1,024 | 1,024 | 1,024 | 1,024 | 1,024 | |
"Free" reserves | Rs m | 55,968 | 68,576 | 86,421 | 102,839 | 102,733 | |
Net worth | Rs m | 56,992 | 69,600 | 87,445 | 103,863 | 103,757 | |
Long term debt | Rs m | 8,964 | 24,684 | 25,551 | 39,497 | 32,146 | |
Total assets | Rs m | 105,506 | 152,207 | 180,653 | 234,831 | 236,866 | |
Interest coverage | x | 40.8 | 37.2 | 26.6 | 13.3 | 5.4 | |
Debt to equity ratio | x | 0.2 | 0.4 | 0.3 | 0.4 | 0.3 | |
Sales to assets ratio | x | 0.9 | 0.6 | 0.7 | 0.6 | 0.6 | |
Return on assets | % | 19.1 | 10.3 | 10.6 | 8.9 | 6.5 | |
Return on equity | % | 34.5 | 21.8 | 20.9 | 18.3 | 11.6 | |
Return on capital | % | 33.3 | 18.0 | 22.0 | 18.3 | 13.7 | |
Exports to sales | % | 47.2 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 6.2 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 44,537 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 5,838 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 44,881 | 21,280 | 42,683 | 48,404 | 52,752 | |
Fx outflow | Rs m | 9,069 | 10,874 | 11,242 | 11,593 | 14,504 | |
Net fx | Rs m | 35,812 | 10,406 | 31,441 | 36,811 | 38,248 |
CADILA HEALTHCARE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 18,935 | 13,117 | 9,193 | 12,819 | 25,054 | |
From Investments | Rs m | -8,635 | -28,719 | -9,737 | -42,387 | -10,123 | |
From Financial Activity | Rs m | -9,348 | 23,158 | 515 | 18,846 | -10,942 | |
Net Cashflow | Rs m | 991 | 7,556 | -29 | -8,109 | 3,989 |
Share Holding
|
Company Information
|
CHM: Pankaj R. Patel (MD) | COMP SEC: Upen H. Shah | YEAR OF INC: 1995 | BSE CODE: 532321 | FV (Rs): 5 | DIV YIELD (%): 0.7 |
Read: CADILA HEALTHCARE 2019-20 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: SHASUN PHARMA PFIZER INDOCO REMEDIES TORRENT PHARMA ORCHID PHARMA
Compare CADILA HEALTHCARE With: SHASUN PHARMA PFIZER INDOCO REMEDIES TORRENT PHARMA ORCHID PHARMA
Compare CADILA HEALTHCARE With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US) TEVA PHARMA (Israel)
Share markets in India are presently trading on a strong note. The BSE Sensex is trading up by 642 points, up 1.3% at 49,206 levels.
Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.
For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.
For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.
More Views on NewsThe smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.
The charts are telling the bulls to be cautious.
Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
Our ace stock picker is ready to capitalise on a big growth opportunity.
More